Αποτελέσματα Αναζήτησης
R76.8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2025 edition of ICD-10-CM R76.8 became effective on October 1, 2024. This is the American ICD-10-CM version of R76.8 - other international versions of ICD-10 R76.8 may differ.
- R76.9
R76.9 is a billable/specific ICD-10-CM code that can be used...
- R76.9
R76.8 is a billable diagnosis code used to specify a medical diagnosis of other specified abnormal immunological findings in serum. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2024 through September 30, 2025.
7 Αυγ 2023 · In the study cohort and the sub-cohort with autoimmune disease, ANA + was associated (P ≤ 5 × 10 –5) with 88 and 136 clinical diagnoses respectively, including lupus (OR ≥ 5.4, P ≤ 7.8 × 10 –202) and other autoimmune diseases and complications.
16 Ιουν 2023 · Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of unknown cause that can affect virtually any organ of the body. Immunologic abnormalities, especially the production of a number of antinuclear antibodies (ANA), are a prominent feature of the disease.
This page provides explanations for the ICD diagnosis code “R76.8 Other specified abnormal immunological findings in serum” and its subcategories.
1 Οκτ 2024 · R76.8 is a valid billable ICD-10 diagnosis code for Other specified abnormal immunological findings in serum. It is found in the 2025 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2024 - Sep 30, 2025.
ICD-9 ICD-10; Lupus: 710.0: M32.9, M 32.10: Scleroderma: ... Frodlund et al. found that 13% of persons with recent onset SLE seroconverted from positive to negative within 8 ... Andrade LEC. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients ...
